Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Research Identifies a Genetic Cause of Hypertension

Published: Thursday, November 22, 2012
Last Updated: Thursday, November 22, 2012
Bookmark and Share
A multinational research project led by the Universities of Dundee and Glasgow has identified a genetic determinant of hypertension, which could inform treatment of the condition for thousands of patients.

Hypertension (high blood pressure) is a commonly inherited condition arising from the interplay between genetic factors and the environment. However, the genes underlying this have proved difficult to identify.
 
This new research has identified a common mutation of the genes which regulate the production of the essential hormones - aldosterone and cortisol - in the adrenal gland as being influential in the development of hypertension.
 
“It has proved very difficult to identify genetic causes of hypertension but this research shows that a gene variation that is present in around 40% of the population is a significant factor,” said Professor John Connell, Vice-Principal of the University of Dundee, who led the project.
 
“Drugs targeting aldosterone are already used in the treatment of hypertension, so this study emphasises that these should be more widely used. It will also inform the development of other therapies that could affect the way that aldosterone is produced.  We know that the effects of aldosterone are amplified by a high salt diet, so this could give an important clue to an interaction between a common genetic variation and the environment.”
 
The project was funded by the Medical Research Council, and led by Professor Connell (University of Dundee) and Professor Eleanor Davies (University of Glasgow), in collaboration with partners across the UK and Europe including the Universities of Cambridge, Aberdeen, Queen Mary London, Oxford and Leicester.
 
The results of the research have been published online by Hypertension, the journal of the American Heart Association.
 
The study utilised data on more than 3000 patients held by the MRC British Genetics of HyperTension (BRIGHT) study and a further 2900 cases from the Nordic Diltiazem study (NORDIL) and the Malmo Cancer and Diet Study.
 
The study built on theoretical models that variations in these genes may be risk factors for hypertension. “One of the extremely satisfying aspects of this research has been that we have been able to take that theory all the way through to firm findings that show how the gene variation leads to altered function,” said Professor Davies.
 
Professor Connell said “We will now look to carry out further research, particularly with regard to the importance of genetically determined variation in aldosterone in other forms of cardiovascular disease.”
 
To view the full paper see:
http://hyper.ahajournals.org/content/early/2012/11/12/HYPERTENSIONAHA.112.200741.abstract.html?ijkey=ZioqEzXNq0LGIpM&keytype=ref


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Liquid Biopsies: Utilization of Circulating Biomarkers for Minimally Invasive Diagnostics Development
Market Trends in Biofluid-based Liquid Biopsies: Deploying Circulating Biomarkers in the Clinic. Enal Razvi, Ph.D., Managing Director, Select Biosciences, Inc.
Watching a Tumour Grow in Real-Time
Researchers from the University of Freiburg have gained new insight into the phases of breast cancer growth.
Childhood Cancer Cells Drain Immune System’s Batteries
Cancer cells in neuroblastoma contain a molecule that breaks down a key energy source for the body’s immune cells, leaving them too physically drained to fight the disease.
Urine Proteins Point to Early-Stage Pancreatic Cancer
A combination of three proteins found at high levels in urine can accurately detect early-stage pancreatic cancer, researchers at the BCI have shown.
Researcher Discovers Trigger of Deadly Melanoma
New research sheds light on the precise trigger that causes melanoma cancer cells to transform from non-invasive cells to invasive killer agents, pinpointing the precise place in the process where "traveling" cancer turns lethal.
Genetic Tug of War
Researchers have reported on a version of genetic parental control in mice that is more targeted, and subtle than canonical imprinting.
Error Correction Mechanism in Cell Division
Cell biologists have reported an advance in understanding the workings of an error correction mechanism that helps cells detect and correct mistakes in cell division early enough to prevent chromosome mis-segregation and aneuploidy, that is, having too many or too few chromosomes.
How to Become a Follicular T Helper Cell
Uncovering the signals that govern the fate of T helper cells is a big step toward improved vaccine design.
Researchers Resurrect Ancient Viruses
Researchers at Massachusetts Eye and Ear and Schepens Eye Research Institute have reconstructed an ancient virus that is highly effective at delivering gene therapies to the liver, muscle, and retina.
Cell Aging Slowed by Putting Brakes on Noisy Transcription
Experiments in yeast hint at ways to extend life of some human cells.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!